SECOND AMENDMENT TO IRREVOCABLE LICENSE AGREEMENTIrrevocable License Agreement • August 8th, 2012 • Amarin Corp Plc\uk • Pharmaceutical preparations
WHEREAS, Licensor and Licensee entered into a License Agreement dated April 11, 2011 for an agreed upon 3,303 square feet of office space located at 1420 Route 206, Bedminster, NJ (the “1420 Premises”); and a First Amendment dated May 11, 2011 which relocated Licensee to Suite # 200 consisting of an agreed-upon 9,747 square feet of office space located in 1430 Route 206, Bedminster, NJ (the “1430 Premises”); and
AMENDMENT TO API COMMERCIAL SUPPLY AGREEMENTApi Commercial Supply Agreement • August 8th, 2012 • Amarin Corp Plc\uk • Pharmaceutical preparations
This AMENDMENT TO API COMMERCIAL SUPPLY AGREEMENT (the “Amendment”) is made as of this 4 day of April, 2012 (the “Amendment Effective Date”), by and between Amarin Pharmaceuticals Ireland Ltd., a corporation organized under the laws of Ireland and having its principal office at First Floor, Block 3, The Oval, Shelbourne Road, Ballsbridge, Dublin 4, Ireland (“Amarin”), and Chemport Inc., a corporation organized under the laws of South Korea and having its principal offices at 15-1, Dongsu-dong, Naju-si, Jeollanam-do 520-330 Korea (“Chemport”).
THIRD AMENDMENT TO IRREVOCABLE LICENSE AGREEMENTIrrevocable License Agreement • August 8th, 2012 • Amarin Corp Plc\uk • Pharmaceutical preparations
WHEREAS, Licensor and Licensee entered into a License Agreement dated April 11, 2011 for an agreed upon 3,303 square feet of office space located at 1420 Route 206, Bedminster, NJ (the “1420 Premises”); a First Amendment dated May 11, 2011 which relocated Licensee to Suite # 200 consisting of an agreed-upon 9,747 square feet of office space located in 1430 Route 206, Bedminster, NJ (the “1430 Premises”) and Second Amendment dated April 25, 2012; and
SUBLEASE AGREEMENTSublease Agreement • August 8th, 2012 • Amarin Corp Plc\uk • Pharmaceutical preparations
THIS SUBLEASE AGREEMENT (“Sublease”) is made and entered into this 25th day of April, 2012, by and among Advance Realty Management, Inc. a New Jersey corporation, having a principal place of business at 1430 Route 206, Bedminster, NJ 07921, (the “Sublessor”) and Amarin Pharma Inc., a Delaware corporation, having a principal place of business at 1430 US Highway 206, Bedminster, New Jersey 07921 (“Sublessee”) and Bedminster 2 Funding, LLC (the “Prime Lessor”).
